LMR Partners’s SeaStar Medical ICU Stock Holding History

LMR Partners’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-700	Closed	-$1.8M	–	1184
2022 Q3	$1.8M	Hold	700	–	–	0.03%	569
2022 Q2	$1.78M	Hold	700	–	–	0.03%	576
2022 Q1	$1.77M	Hold	700	–	–	0.02%	611
2021 Q4	$1.76M	Hold	700	–	–	0.02%	517
2021 Q3	$1.76M	Hold	700	–	–	0.02%	493
2021 Q2	$1.73M	Buy	+700	New	+$1.73M	0.03%	401

Other funds holding ICU

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

CCFM

Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return

SWA

SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LMR Partners's ICU Position: Q4 2022 in Review

LMR Partners sold out of SeaStar Medical (ICU) in Q4 2022, closing a stake of 700 shares — an estimated $1.8M sold.

LMR Partners first reported a position in ICU in Q2 2021 and held it in 6 quarters. The position peaked at $1.8M in Q3 2022. 8 funds tracked by Wall St. Rank hold ICU as of Q4 2022.

LMR Partners reported no remaining SeaStar Medical position as of Q4 2022 after selling out during the quarter.
LMR Partners sold 700 SeaStar Medical shares in Q4 2022, an estimated $1.8M.
LMR Partners first reported a position in SeaStar Medical in Q2 2021 and held it in 6 quarters.
LMR Partners's SeaStar Medical position peaked at $1.8M in Q3 2022.
8 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.